Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

0 Followers
JP:2689

OLBA HEALTHCARE HOLDINGS, Inc.

(TSE/TYO:2689)

Select Model
Rating:62Neutral
Price Target:JPY 2,015.00â–²(10.35% Upside)
Action:reiterated
Date:08/17/26

The score is driven primarily by mixed financial quality: rapid sales growth and a conservative balance sheet are offset by thin/declining margins and negative free cash flow in 2026. Valuation is a clear positive (low P/E and strong dividend yield), but weak technicals (below key moving averages and negative MACD) limit the overall score.

Positive Factors
Accelerating Revenue GrowthThe sharp 2026 revenue increase indicates strong demand, expanded distribution activity, or improved market penetration. Sustained top-line momentum can support operating scale and strengthen the company’s competitive position if profitability is restored.
Negative Factors
Thin and Declining MarginsVery low and weakening margins leave limited protection against supplier costs, labor expense, pricing pressure, or unfavorable product mix. Continued compression could prevent strong revenue growth from translating into durable earnings and internal cash generation.

OLBA HEALTHCARE HOLDINGS, Inc. (2689) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%JP:2689-5.53%EWJ+15.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 19.09B
Dividend Yield
4.38%
Average Volume (3M)
3,445
Price to Earnings (P/E)
11.3
Beta (1Y)
0.10
Revenue Growth
2.20%
EPS Growth
-31.67%
Country
Japan
Employees
1,405
Sector
General
Sector Strength
55
Industry
Medical - Distribution

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institutio...

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

Strong 2026 revenue growth (~47% YoY) supports fundamentals, and leverage is manageable (debt-to-equity ~0.22). Offsetting this, profitability is very thin and weakened (net margin ~0.9%), and cash conversion is a key concern with volatile operating cash flow and negative free cash flow in 2026.

Income Statement

66Positive

Balance Sheet

78Positive

Cash Flow

44Neutral
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue126.60B126.60B122.70B118.56B110.47B107.96B
Gross Profit14.18B14.18B13.91B13.60B12.95B12.50B
EBITDA2.21B2.42B2.59B2.83B2.68B2.56B
Net Income1.11B1.11B1.43B1.50B1.41B1.54B
Balance Sheet
Total Assets46.65B46.65B45.87B43.24B40.88B39.97B
Cash, Cash Equivalents and Short-Term Investments2.64B2.64B3.47B2.73B2.40B3.19B
Total Debt2.89B2.89B2.95B1.63B1.92B1.28B
Total Liabilities33.59B33.59B33.62B31.86B30.55B30.88B
Stockholders Equity13.06B13.06B12.26B11.37B10.33B9.09B
Cash Flow
Free Cash Flow0-388.56M181.25M1.61B-910.52M1.97B
Operating Cash Flow0864.57M1.63B2.08B-659.52M2.42B
Investing Cash Flow0-1.11B-1.64B-673.03M-306.25M-211.81M
Financing Cash Flow0-590.53M686.95M-1.09B175.94M-1.17B

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price1826.00

Price Trends

50DMA1911.54Negative
100DMA1911.84Negative
200DMA1963.76Negative

Market Momentum

MACD-18.24Positive
RSI23.50Positive
STOCH5.04Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 1826.00 is below the 20-day moving average (MA) of 1899.35, below the 50-day MA of 1911.54, and below the 200-day MA of 1963.76, indicating a bearish trend. The MACD of -18.24 indicates Positive momentum. The RSI at 23.50 is Positive, neither overbought nor oversold. The STOCH value of 5.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:2689 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6062JP:606273OutperformJPY 64.01B15.85―2.19%5.50%45.42%
JP:7071JP:707164NeutralJPY 36.28B11.37―1.09%6.17%-33.01%
JP:2689JP:268962NeutralJPY 19.14B11.25―4.38%2.20%-31.67%
JP:9265JP:926556NeutralJPY 9.41B16.79―2.89%-0.41%2.32%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:3417JP:341752NeutralJPY 13.47B18.54―3.06%2.87%-73.55%

* General Sector Average

Performance Comparison

-20%0%20%40%60%JP:2689JP:3417JP:6062JP:7071JP:9265Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:2689 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:2689OLBA HEALTHCARE HOLDINGS, Inc.1826.00-101.12-5.25%
JP:3417Ohki Health Care Holdings, Inc.980.00-400.65-29.02%
JP:6062Charm Care Corporation1962.00761.1663.39%
JP:7071Amvis Holdings.Inc.368.00-89.33-19.53%
JP:9265YAMASHITA HEALTH CARE HOLDINGS, INC.3700.00557.2817.73%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration

Aug 12, 2026

OLBA Healthcare Holdings reported consolidated net sales of ¥126,595 million for the fiscal year ended June 30, 2026, up 3.2% year on year, while operating profit fell 15.2% to ¥1,679 million and profit attributable to owners of the parent dropped 22...

OLBA Healthcare and DVx to Merge via Share Exchange Amid Mounting Sector Pressures

May 22, 2026

OLBA HEALTHCARE HOLDINGS and DVx Inc. have agreed to a business integration via a share exchange that will make OLBA HEALTHCARE the wholly owning parent and DVx its wholly owned subsidiary, with the transaction scheduled to take effect on September 1...

OLBA Sets Record Date for Vote on DVx Business Integration

May 22, 2026

OLBA HEALTHCARE HOLDINGS, Inc. has set June 8, 2026, as the record date to determine shareholders eligible to vote at an upcoming extraordinary general meeting. The company will provide notice electronically via its website, establishing which invest...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026